Philogen

Basic Information

• Category: business
• Founded: 2023
• Website: https://www.philogen.com/

Documented Facts

• Email: afc@pec.philogengroup.it (No linked source recorded for this statement.)
• Founded: 1996 (No linked source recorded for this statement.)
• Stock ticker: S (Italian) (No linked source recorded for this statement.)

Evidence and Sources

• Philogen — Official Site (official)
• Philogen on linkedin (social)

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Philogen.

• Canonical profile: https://brandsource.ai/brands/philogen
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/philogen/json-ld
• Citation profile API: https://brandsource.ai/api/brands/philogen/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (87/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-22

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 1 supporting source linked.
• 3 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.